CARLOS MANUEL
PANIZO SANTOS
Hospital Virgen del Camino
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (10)
2024
-
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
The Lancet Haematology, Vol. 11, Núm. 2, pp. e136-e146
2021
-
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Blood Cancer Journal, Vol. 11, Núm. 12
2020
-
RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group
Annals of Hematology, Vol. 99, Núm. 4, pp. 799-808
-
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
British Journal of Haematology, Vol. 188, Núm. 5, pp. 661-673
2019
-
Burkitt-like lymphoma with 11q aberration: A germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
Haematologica, Vol. 104, Núm. 9, pp. 1822-1829
2018
-
Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia
Immunotherapy, Vol. 10, Núm. 6, pp. 491-499
2016
2013
2012
-
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain
Leukemia Research, Vol. 36, Núm. 6, pp. 709-714
1994
-
Seroprevalence of hepatitis B virus markers in pregnant women attending a public hospital in Navarra
Revista clínica española, Vol. 194, Núm. 10, pp. 891-896